Skip to content
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the […]
BIO files amicus brief challenging IRA drug price controls Read More »
Members of the public shared emotional stories about how practices by pharmacy benefit managers (PBMs) increase the cost of drugs, reduce patient access, and
Emotional testimonies expose harmful impact of PBMs at FTC hearing Read More »
The heads of the three largest pharmacy benefit managers (PBMs) were grilled on July 23 by the House Oversight and Accountability Committee, whose new
House Oversight Committee grills PBM executives over ‘despicable’ practices Read More »
Farmers, biotech firms, the federal government, and other stakeholders are cooperating closely to tackle the emerging challenge of protecting cattle against avian flu, said
Public-private partnerships drive response to avian flu in cattle, panel says Read More »
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the
BIO Board member and head of BioUtah testify at House field hearing Read More »
With rapid innovations in agriculture, energy, and environmental biotech, the industry must try to educate regulators and the public about the latest scientific advances
BIO 2024: Education can improve regulation, biotech innovators say Read More »
Getting government support for a biotech startup no longer need be a slow and painful process, according to staff and fundees of the Advanced
ARPA-H offers fast, flexible support to biotech startups, panelists tell BIO 2024 Read More »
Biopharma supply chains, streamlining regulation, and other critical issues came up when the leader of the U.S. agency regulating drugs spoke with the leader
FDA’s Dr. Califf talks supply chains, clinical trial diversity, and America’s health Read More »
The pollster pulled no punches: The biopharma industry has a poor public image, and politicians in both parties are ready to back drug price
Biotech needs to polish its message as elections approach, experts say Read More »
To ensure national security in the face of potential biological threats, the U.S. government relies on a partnership with biotech firms, federal officials explained
BIO 2024: U.S. officials describe national security partnership with biotech Read More »
